Aevi Genomic Medicine, Llc, A Cerecor Company

This early-stage study tested a new drug called NFC-1 in 30 teenagers aged 12-17 with ADHD who also have certain gene changes. The goal was to see if the drug is safe and how it affects ADHD symptoms over four weeks. Researchers measured side effects, drug levels in the blood, an…